Short answer · Medically reviewed summary · Last updated: 2026-05-08
Holmes-Adie Syndrome, also known as Adie's tonic pupil, was independently described in 1931 by British neurologist Gordon Holmes and British physician William John Adie. It is a benign neurological disorder characterized by a tonic, poorly reactive pupil and diminished deep tendon reflexes, and it is now recognized as a post-viral or autoimmune peripheral neuropathy rather than a sinister central nervous system lesion. Who first discovered Holmes-Adie Syndrome? In 1931, Gordon Holmes and William John Adie published separate papers in the journal Brain, detailing patients who presented with a pupil that reacted slowly to light but showed a stronger response to near-vision accommodation.
Holmes-Adie Syndrome, also known as Adie's tonic pupil, was independently described in 1931 by British neurologist Gordon Holmes and British physician William John Adie. It is a benign neurological disorder characterized by a tonic, poorly reactive pupil and diminished deep tendon reflexes, and it is now recognized as a post-viral or autoimmune peripheral neuropathy rather than a sinister central nervous system lesion.
In 1931, Gordon Holmes and William John Adie published separate papers in the journal Brain, detailing patients who presented with a pupil that reacted slowly to light but showed a stronger response to near-vision accommodation. While a French physician, Maurice Nonne, had observed similar cases earlier, the definitive clinical characterization by Holmes and Adie solidified Holmes-Adie Syndrome as a distinct medical entity.
Initially, physicians feared that the loss of deep tendon reflexes and pupillary changes associated with Holmes-Adie Syndrome indicated serious conditions like tabes dorsalis (syphilis). Over the 20th century, clinical observation and the advent of refined diagnostic tools proved that Holmes-Adie Syndrome is a benign, non-progressive condition. Modern research suggests it is caused by damage to the ciliary ganglion and the dorsal root ganglia, often triggered by a viral or bacterial infection that induces an inflammatory response.
The medical community transitioned from relying on clinical suspicion to using pharmacological testing to confirm the diagnosis. Key milestones include:
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.